Login / Signup

Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy.

Lusha W LiangYoshihiko RaitaKohei HasegawaMichael A FiferMathew S MaurerMuredach P ReillyYuichi J Shimada
Published in: Heart (British Cardiac Society) (2022)
Our prospective plasma proteomics study not only exhibited the presence of HCM molecular subtypes but also identified pathobiological mechanisms associated with a distinct high-risk subtype of HCM.
Keyphrases
  • hypertrophic cardiomyopathy
  • left ventricular
  • mass spectrometry
  • label free
  • single molecule
  • single cell
  • heart failure